52-week high alert: Pharma stock hit upper circuit as it announces outstanding results; India's leading fund buys stake in it!
52-week high alert: Pharma stock hit upper circuit as it announces outstanding results; India's leading fund buys stake in it!

52-week high alert: Pharma stock hit upper circuit as it announces outstanding results; India's leading fund buys stake in it!

The stock has impressive ROCE of 172 per cent and ROE of 129 per cent  

Vaishnavi Chauhan Article rating: 4.2

The operating profit witnessed a significant increase of 145.11 per cent on YoY basis, amounting to Rs 10.54 crore. Furthermore, company’s net profit showed a massive jump of 147.81 per cent from FY22, reaching Rs 8.50 crore.  

  

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR